Who owns NAUTILUS BIOTECHNOLOGY INC?
- Ticker: NAUT
- CUSIP Number: 63909j108
Tip: Access positions for across all investors
Analyze quarterly positions in Nautilus Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Nautilus Biotechnology stock
Who bought or sold NAUTILUS BIOTECHNOLOGY INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
AH Capital Management | 18M | $52M | 0% | Mar 2024 |
|
Perceptive Advisors | 13M | $37M | 0% | Mar 2024 |
|
Cercano Management | 7.2M | $21M | 0% | Mar 2024 |
|
Madrona Venture Group | 6.0M | $18M | 0% | Mar 2024 |
|
BlackRock | 3.7M | $11M | 0% | Mar 2024 |
|
Vanguard Group | 2.9M | $8.4M | 1% | Mar 2024 |
|
Comprehensive Financial Management | 2.2M | $6.5M | 0% | Mar 2024 |
|
Bain Capital Life Sciences Investors | 2.0M | $5.9M | 0% | Mar 2024 |
|
Amazon | 1.5M | $4.3M | 0% | Mar 2024 |
|
Geode Capital Management | 1.1M | $3.3M | 9% | Mar 2024 |
|
Clarius | 620k | $1.8M | 4% | Mar 2024 |
|
Northern Trust | 514k | $1.5M | -4% | Mar 2024 |
|
Dimensional Fund Advisors | 480k | $1.4M | 20% | Mar 2024 |
|
Alyeska Investment Group | 441k | $1.3M | 0% | Mar 2024 |
|
Morgan Stanley | 407k | $1.2M | 1% | Mar 2024 |
|
_Sentinel Trust Company, LBA______________ | 310k | $911k | 3% | Mar 2024 |
|
Hillman | 200k | $588k | 0% | Mar 2024 |
|
Nuveen Asset Management | 194k | $569k | 2% | Mar 2024 |
|
Clearline Capital | 169k | $497k | -28% | Mar 2024 |
|
Wexford Capital | 159k | $468k | 100% | Mar 2024 |
|
Bank of New York Mellon | 141k | $415k | -6% | Mar 2024 |
|
Charles Schwab Investment Management | 136k | $401k | 0% | Mar 2024 |
|
Barclays | 77k | $227k | -31% | Mar 2024 |
|
Rhumbline Advisers | 75k | $220k | 3% | Mar 2024 |
|
Citadel Advisors | 71k | $210k | -44% | Mar 2024 |
|
Jpmorgan Chase & Co | 64k | $188k | 6% | Mar 2024 |
|
Goldman Sachs Group | 63k | $185k | -6% | Mar 2024 |
|
UBS Group | 52k | $152k | -9% | Mar 2024 |
|
Signature | 37k | $110k | 0% | Mar 2024 |
|
Vanguard Capital Wealth Advisors | 37k | $107k | -9% | Mar 2024 |
|
Jane Street | 31k | $90k | -42% | Mar 2024 |
|
MetLife Investment Advisors | 28k | $84k | 0% | Dec 2023 |
|
Virtu Financial | 26k | $79k | 100% | Dec 2023 |
|
American International | 25k | $75k | 0% | Dec 2023 |
|
China Universal Asset Management | 24k | $71k | 67% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 22k | $66k | -32% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 21k | $62k | 100% | Mar 2024 |
|
Millennium Management | 21k | $61k | 85% | Mar 2024 |
|
SG Americas Securities | 20k | $59k | -29% | Mar 2024 |
|
Hsbc Holdings | 19k | $60k | 0% | Dec 2023 |
|
Wells Fargo & Company | 18k | $53k | 14% | Mar 2024 |
|
Ing Investment Management | 18k | $53k | -16% | Mar 2024 |
|
ProShare Advisors | 18k | $52k | 21% | Mar 2024 |
|
Alliancebernstein | 17k | $49k | -1% | Dec 2023 |
|
T. Rowe Price Associates | 16k | $48k | 36% | Mar 2024 |
|
XTX Topco | 12k | $34k | 100% | Mar 2024 |
|
Citigroup | 11k | $32k | 4% | Mar 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 10k | $30k | -6% | Mar 2024 |
|
Presidio Capital Management | 10k | $29k | 0% | Mar 2024 |
|
Axxcess Wealth Management | 10k | $30k | 100% | Dec 2023 |
|
Bank of America Corporation | 9.7k | $29k | -77% | Mar 2024 |
|
Federated Investors | 9.5k | $28k | 4% | Dec 2023 |
|
New York State Common Retirement Fund | 8.6k | $25k | -1% | Mar 2024 |
|
California State Teachers Retirement System | 5.1k | $15k | -54% | Mar 2024 |
|
FMR | 4.4k | $13k | 4% | Mar 2024 |
|
Legal & General Group | 4.1k | $12k | 0% | Mar 2024 |
|
Tower Research Capital | 3.9k | $12k | -13% | Mar 2024 |
|
Advisor Group Holdings | 3.8k | $11k | -12% | Mar 2024 |
|
Summit Investment Advisors | 3.6k | $11k | 0% | Mar 2024 |
|
Amalgamated Bank | 1.7k | $5.0k | -63% | Mar 2024 |
|
Brian McDonald | 1.2k | $3.6k | -31% | Mar 2024 |
|
Royal Bank of Canada | 1.2k | $0 | -93% | Mar 2024 |
|
TD Waterhouse Canada | 1.0k | $2.7k | 0% | Mar 2024 |
|
Metropolitan Life Insurance Company | 803.00 | $2.4k | -74% | Dec 2023 |
|
Daiwa Securities Group | 362.00 | $999.988800 | 0% | Mar 2024 |
|
Eagle Bay Advisors | 337.00 | $991.015900 | 0% | Mar 2024 |
|
Simplex Trading | 216.00 | $0 | -74% | Mar 2024 |
|
Atlantic Trust | 200.00 | $600.000000 | 100% | Mar 2024 |
|
Your Advocates | 150.00 | $441.000000 | 0% | Mar 2024 |
|
GAMMA Investing | 105.00 | $309.004500 | 0% | Mar 2024 |
|
NISA Investment Advisors | 15.00 | $43.999500 | 0% | Mar 2024 |
|
Covestor | 7.00 | $0 | 0% | Mar 2024 |
|
CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Nautilus Biotechnology?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Botty Investors | Sep 2023 | 1.4M | $4.6M |
Bridgeway Capital Management | Sep 2023 | 39k | $123k |
Florida State Board of Administration | Dec 2023 | 15k | $43k |
Susquehanna International | Sep 2023 | 12k | $38k |
Pnc Financial Services | Dec 2023 | 11.00 | $33.000000 |